WHO ICTRP trial
A clinical trial to study the effect of drug on IQ and behavioral problem in…
CTRI/2008/091/000229 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2008/091/000229 |
|---|---|
| Public title | A clinical trial to study the effect of drug on IQ and behavioral problem in Children with Fragile X Syndrome |
| Scientific title | A Randomized, Double-Blind, Placebo-Controlled Study of Donepezil on Cognitive Function and Behaviour in Children with Fragile X Syndrome |
| Primary sponsor | Dr Jitendra Kumar Sahu |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: F79- Unspecified intellectual disabilities |
| Interventions | Intervention1: Donepezil: 2.5mg od for the first 4 weeks than 5 mg od for the next 8 weeks Control Intervention1: Placebo: 2.5mg od for the first 4 weeks than 5 mg od for the next 8 weeks |
| Registration date | Jan 19, 2009 |
| Target size | 0 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: